Stockreport

Innate Pharma Provides Update from Regulatory Agencies on Lacutamab TELLOMAK Trial

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF MARSEILLE, France, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announ [Read more]